Celularity (CELU) Gross Margin (2020 - 2026)
Celularity's Gross Margin came in at -79.68% for Q4 2025, down 139.18 percentage points from 59.50% a year earlier and down 105.79 percentage points from the prior quarter.
Powered by 
Analysis
Celularity (CELU) Gross Margin (2020 - 2026) Analysis & Trends
For FY2025, Celularity's Gross Margin was 24.39%, down 47.96 percentage points from FY2024.
- Gross Margin carries a five-year change of -41.07 percentage points (FY2020 to FY2025).
- Going back by year, Gross Margin was 72.36% in FY2024 (+42.69 pp), 29.66% in FY2023 (+39.07 pp), -9.40% in FY2022 (-64.16 pp) and 54.76% in FY2021 (-10.70 pp).
- The Q4 2025 figure represents the lowest quarterly Gross Margin in data going back to Q3 2020.
- Year-over-year, Gross Margin has declined for four consecutive quarters, with an average year-over-year change of -15.42 percentage points over the last eight quarters.
- The fastest year-over-year change in Gross Margin over five years came in Q3 2023 (a gain of 79.30 percentage points), and the weakest in Q3 2022 (a drop of 152.68 percentage points).
- Business Quant data shows CELU's Gross Margin at 26.12% (Q3 2025), 8.61% (Q2 2025) and 68.90% (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 85.33% |
| 10 | Celularity | 39.39 Mn | 31.87 Mn | 2.39 Mn | 62.25% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 62.25% |
| Dec 31, 2025 | -79.68% |
| Sep 30, 2025 | 26.12% |
| Jun 30, 2025 | 8.61% |
| Mar 31, 2025 | 68.90% |
| Dec 31, 2024 | 59.50% |
| Sep 30, 2024 | 58.23% |
| Jun 30, 2024 | 82.47% |
| Mar 31, 2024 | 88.83% |
| Dec 31, 2023 | 20.67% |
| Sep 30, 2023 | 4.86% |
| Jun 30, 2023 | 72.70% |
| Mar 31, 2023 | 49.10% |
| Dec 31, 2022 | -27.08% |
| Sep 30, 2022 | -74.44% |
| Jun 30, 2022 | 15.81% |
| Mar 31, 2022 | 32.17% |
| Dec 31, 2021 | 4.04% |
| Sep 30, 2021 | 78.24% |
| Jun 30, 2021 | 54.96% |
API Access
Celularity Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=CELU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "CELU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=CELU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();